Diverse neurological effects linked to anti-PD-1 therapy
(HealthDay)—Neurological complications associated with anti-programmed death 1 (PD-1) antibody treatment have a diverse phenotype, according to a study published online Sept. 5 in JAMA Neurology.
Sep 11, 2017
0
1